Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/19/1998 | CA2287839A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
11/19/1998 | CA2286875A1 Chemical compounds |
11/19/1998 | CA2261025A1 Novel polyketide derivatives and recombinant methods for making same |
11/19/1998 | CA2221866A1 A novel member of the il-1 family, il-1 delta |
11/18/1998 | EP0878554A2 Detection of nucleic acids by fluorescence quenching |
11/18/1998 | EP0878553A2 Strand displacement amplification of RNA targets |
11/18/1998 | EP0878552A1 Molecular detection of chromosome aberrations |
11/18/1998 | EP0878547A1 Methods for producing retroviruses with an altered tropism |
11/18/1998 | EP0878546A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
11/18/1998 | EP0878545A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/18/1998 | EP0878544A1 Epididymis specific DNA sequences and their use |
11/18/1998 | EP0878543A1 cDNA FRAGMENTS OF GENE CAUSATIVE OF SPINOCEREBELLAR ATAXIA TYPE 2 |
11/18/1998 | EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
11/18/1998 | EP0878479A2 G-protein coupled receptor (HOFNH30) |
11/18/1998 | EP0877937A1 Method of managing the chemotherapy of patients who are hiv positive based on the phenotypic drug sensitivity of human hiv strains |
11/18/1998 | EP0877820A1 Diagnostic test to determine the malignancy of smooth muscle tumors |
11/18/1998 | EP0877819A1 Disruption of expression of multiple alleles of mammalian genes |
11/18/1998 | EP0877818A1 Process for activating a kinase |
11/18/1998 | EP0877816A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
11/18/1998 | EP0877814A1 Raspberry promoters for expression of transgenes in plants |
11/18/1998 | EP0877813A1 Plant tissue/stage specific promoters for regulated expression of transgenes in plants |
11/18/1998 | EP0877812A1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
11/18/1998 | EP0877811A1 Mutated prenyl diphosphate synthases |
11/18/1998 | EP0877810A1 Methods and compositions for inhibiting hexokinase |
11/18/1998 | EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
11/18/1998 | EP0877808A1 Decorin binding protein compositions and methods of use |
11/18/1998 | EP0877807A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
11/18/1998 | EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
11/18/1998 | EP0877805A1 Tandem fluorescent protein constructs |
11/18/1998 | EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto |
11/18/1998 | EP0877803A1 Ob protein receptor and related compositions and methods |
11/18/1998 | EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
11/18/1998 | EP0877801A2 Morphological mutants of filamentous fungi |
11/18/1998 | EP0877798A1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
11/18/1998 | EP0877797A1 Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
11/18/1998 | EP0877796A1 Compositions and methods for mediating cell cycle progression |
11/18/1998 | EP0877795A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
11/18/1998 | EP0877794A1 Method capable of increasing competency of bacterial cell transformation |
11/18/1998 | EP0877793A1 Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase |
11/18/1998 | EP0877760A1 Mhc complexes and uses thereof |
11/18/1998 | EP0877758A2 PURIFIED SR-p70 PROTEIN |
11/18/1998 | EP0877756A1 Anti-microbial protein |
11/18/1998 | EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
11/18/1998 | EP0877754A2 AMINO ACID-ENRICHED PLANT PROTEIN RESERVES, PARTICULARLY LYSINE-ENRICHED MAIZE $g(g)-ZEIN, AND PLANTS EXPRESSING SUCH PROTEINS |
11/18/1998 | EP0877752A1 Methods for screening for transdominant effector peptides and rna molecules |
11/18/1998 | EP0877627A1 Obesity protein analog compounds and formulations thereof |
11/18/1998 | EP0877549A1 Methods and compositions for the reduction of xenotransplantation rejection |
11/18/1998 | EP0877547A1 Plant glutamate receptors |
11/18/1998 | EP0690990B1 Parvovirus receptors and methods of use |
11/18/1998 | EP0658213B1 Multiple antibiotic resistance operon assays |
11/18/1998 | EP0581836B1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
11/18/1998 | EP0551501B1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
11/18/1998 | EP0550519B1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
11/18/1998 | EP0451141B1 Immobilized sequence-specific probes |
11/18/1998 | CN1199425A DNA constructs |
11/18/1998 | CN1199424A Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
11/18/1998 | CN1199423A Nuclear-encoded transcription system in plastids of higher plants |
11/18/1998 | CN1199422A Transgenic non-human animals capable of producing heterologous antibodies |
11/18/1998 | CN1199321A Modified bacillus thuringiensis gene for lepidopteran control in plants |
11/18/1998 | CN1199097A Fused gene of IL-2 or its derivative and ANP or its derivative, three kinds of protein product thereof and their application, and vector containing said gene and construction method thereof |
11/18/1998 | CN1199096A Regulatory sequence of alpha-fetoprotein gene expression and its application |
11/18/1998 | CN1040772C Method for obtaining gene of 2-amino-4-methylphosphinebutyric acid |
11/17/1998 | US5837876 Root cortex specific gene promoter |
11/17/1998 | US5837875 Insulin growth factor, expressed in pancreas |
11/17/1998 | US5837860 Immobilizing nucleic acid molecules to solid-phases |
11/17/1998 | US5837858 Method for polymer synthesis using arrays |
11/17/1998 | US5837857 Rna for cell transformation and genetic engineering |
11/17/1998 | US5837856 Chirally enriched synthetic phosphonate oligomers |
11/17/1998 | US5837855 Rna substrates, helices for gene expression, cells, dna and genetic engineering |
11/17/1998 | US5837854 Oligonucleotides with anti-Epstein-Barr virus activity |
11/17/1998 | US5837853 Preventive or therapeutic agents for alzheimers disease a screening method of alzheimers disease and tau-protein kinase I originated from human being |
11/17/1998 | US5837852 Phosphorylated oligonucleotide use as antiinfluenza agent, enzyme inhibitor not dephosphorylated by viral polymerase and inhibitors of influenza transcription |
11/17/1998 | US5837851 DNA promoter 5126 and constructs useful in a reversible nuclear genetic system for male sterility in transgenic plants |
11/17/1998 | US5837850 Maize pollen production controllers; male-sterile plants; gene expression; genetic engineering |
11/17/1998 | US5837849 Octopine synthase; dna fragment which is plant enhancer capable of activating transcription level of plant-expressible gene |
11/17/1998 | US5837848 Root-specific promoter |
11/17/1998 | US5837847 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
11/17/1998 | US5837846 Biosynthetic binding proteins for immuno-targeting |
11/17/1998 | US5837844 CAIP-like gene family |
11/17/1998 | US5837842 Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use |
11/17/1998 | US5837841 Human Reg protein |
11/17/1998 | US5837839 Cloning and gene expression of saccharomyces |
11/17/1998 | US5837834 High affinity HKGF nucleic acid ligands and inhibitors |
11/17/1998 | US5837833 Materials and methods for detection of oxalate |
11/17/1998 | US5837825 Campylobacter jejuni flagellin/Escherichia coli LT-B fusion protein |
11/17/1998 | US5837824 Binds to monoclonal antibody bw 835, dsm acc 2022; use of epitope for diagnosis and therapy |
11/17/1998 | US5837823 Antibodies to adrenomedullin |
11/17/1998 | US5837822 Intercellular adhesion molecule polypeptide; genetic engineering; gene expression; antiinflammatory agents |
11/17/1998 | US5837821 Antibody construct |
11/17/1998 | US5837820 Seed specific biotinylated protein, SBP65, from leguminous plants |
11/17/1998 | US5837819 Amino acid sequences for proteins and signals |
11/17/1998 | US5837818 Construction and expression of synthetic genes encoding envelope epitopes of the human T cell leukemia virus type I |
11/17/1998 | US5837816 Hetero-macromolecular coiled-complexes comprising at least three heptapeptide fusion proteins at least two are different, non-covalently binding to one another for binding interleukin in membrane |
11/17/1998 | US5837815 Amino acid sequences with phosphorylation activity |
11/17/1998 | US5837814 Drug delivery; medical diagnosis; separations; protein fusion products |
11/17/1998 | US5837812 Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides |
11/17/1998 | US5837811 Proteins active in lymphocyte-mediated cytotoxicity |
11/17/1998 | US5837694 Method for enhancing neurone survival and agents useful for same |
11/17/1998 | US5837686 Polypeptides for antiarthritic agents |
11/17/1998 | US5837681 Cell degeneration in ears with administering glial cell neurotropic factor protein for hearing loss |